Saitama Medical University · Faculty of Medicine / Graduate School of Medicine · 講師

Research keywordstype 2 diabetes dyslipidemia・anagliptin・adiponectin and glucose tolerance・coronary artery calcification・PCSK9 inhibitor therapy・cardiometabolic risk

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Anagliptin Monotherapy for Six Months in Patients With Type 2 Diabetes Mellitus and Hyper-Low-Density Lipoprotein Cholesterolemia Reduces Plasma Levels of Fasting Low-Density Lipoprotein Cholesterol and Lathosterol: A Single-Arm Intervention Trial.
• Involvement of low adiponectin levels in impaired glucose tolerance.
• 自己免疫性急性発症1型糖尿病に悪性貧血を合併した1例
• The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapy

• Official profile